Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novo Holdings
Pharma
FTC to review Novo Holdings' Catalent buyout for 30 more days
After Novo Holdings pitched a $16.5 billion buyout of Catalent in February, the companies have given the FTC extra time to review the deal.
Fraiser Kansteiner
Apr 8, 2024 11:58am
Catalent reorg leaves 300 without jobs as CDMO awaits buyout
Feb 15, 2024 8:45am
Catalent's Indiana filling plant in hot water with the FDA again
Feb 7, 2024 2:11pm
Novo Holdings pays $16.5B to scoop up CDMO giant Catalent
Feb 5, 2024 10:22am
Xellia to axe 80 positions at Ohio plant previously owned by BI
Dec 13, 2023 9:19am
Paratek's $462M sale under threat from investor NexPoint
Jun 28, 2023 2:03pm